NPI registry status
Active
2026 NPPES data Urology Physician NPI 1053342386 MD
Verify on CMS → Mark Weintraub, MD
Urology Physician in Bradenton, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,367 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 642 beneficiaries · Urology Physician avg: 1K
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$996.06
36 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mark Weintraub, MD reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 2,453 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 2K
- Part D claims, 2023
- 88%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Weintraub, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Weintraub, MD sits
This provider among urology physician peers
Across the 4,623 urology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Weintraub, MD writes more Part D claims than 79% of them and scores higher on MIPS quality than 12% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one urology physician peer from a representative sample of 60; the gold marker is Mark Weintraub, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Weintraub, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Weintraub, MD?
Below national averagePrimary specialty
Urology Physician
Medicare Part D claims
2,453 92% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in Florida
How Urology Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Mark Weintraub, MD's 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Urology Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Weintraub, MD appears in the CMS NPPES registry as a Urology Physician provider holding MD credentials at 200 3RD AVE W, Bradenton, FL, 34205, with a listed phone of (941) 792-0340. NPI 1053342386 was issued on 07/05/2006.
Medicare Part D records for calendar year 2023 show 2,453 prescription claims written by this provider, covering 642 Medicare beneficiaries and totaling roughly $1.7 million in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 2.6%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Urology Physician is a mid-sized specialty nationwide, with 13,367 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1053342386 |
|---|---|
| Specialty | Urology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/05/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Individual
Hospital and facility affiliations
Facilities where Mark Weintraub, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Precision Healthcare Specialists, LLC
Bradenton, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Weintraub, MD. Source: openpaymentsdata.cms.gov.
Total received
$996
Largest payer
Axonics, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Mark Weintraub, MD. To verify Mark Weintraub, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Mark Weintraub, MD - brand share 12.0%
Urology Physician average
12% brand-name claims vs 88% generic, on 2,453 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,453
Total Claims
$1.7M
Total Drug Cost
642
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,817
- Total Day Supply
- 131,443
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $1.6M
- Generic Drug Cost
- $78K
- Opioid Claims
- 65 (2.6% rate)
- Antibiotic Claims
- 635
Patient Demographics
- Average Patient Age
- 75.6 years
- Avg HCC Risk Score
- 1.59
- Gender Split
- 21% female / 79% male
- Age Distribution
- <65: 33, 65-74: 270, 75-84: 242, 85+: 97
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Weintraub, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Tamsulosin Hcl
Tamsulosin Hcl
528 claims
- Sulfamethoxazole-T… 173
Sulfamethoxazole-Trimethoprim
173 claims
- Alfuzosin Hcl Er 162
Alfuzosin Hcl Er
162 claims
- Dutasteride 114
Dutasteride
114 claims
- Finasteride 97
Finasteride
97 claims
- Levofloxacin 94
Levofloxacin
94 claims
- Ciprofloxacin Hcl 81
Ciprofloxacin Hcl
81 claims
- Amoxicillin-Clavul… 80
Amoxicillin-Clavulanate Potass
80 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 528 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 173 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 162 |
| Dutasteride | 114 |
| Finasteride | 97 |
| Levofloxacin | 94 |
| Ciprofloxacin Hcl | 81 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 80 |
| Testosterone Cypionate | 68 |
| Solifenacin Succinate | 67 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How Mark Weintraub, MD fits within the Urology Physician landscape nationally.
13,367
Urology Physician Providers in US
54
States with Urology Physician
1,280
Avg Claims per Provider
Mark Weintraub, MD's 2,453 claims are above the specialty average of 1,280.
Nearby Urology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Weintraub.
Dr. Abd-El-Rahman Abd-El-Barr
M.D.
Tampa, FL
Dr. Mourad Abouelleil
M.D.
West Palm Beach, FL
Dr. Ran Abrahamy
MD
Tamarac, FL
Dr. Mark Abramson
M.D.
Jacksonville, FL
Dr. Salim Afridi
MD
Plant City, FL
Compare Urology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Urology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Florida
Frequently Asked Questions
What is Mark Weintraub, MD's specialty? ▼
Mark Weintraub, MD specializes in Urology Physician and practices in Bradenton, Florida. Credentials: MD.
How much does Mark Weintraub, MD prescribe under Medicare Part D? ▼
In 2023, Mark Weintraub, MD wrote 2,453 Medicare Part D claims totaling $1.7M in drug costs for 642 beneficiaries.
What is Mark Weintraub, MD's Medicare quality score? ▼
Mark Weintraub, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Weintraub, MD located? ▼
Mark Weintraub, MD is located at 200 3RD AVE W, Bradenton, FL, 34205. Phone: (941) 792-0340.
What is Mark Weintraub, MD's NPI number? ▼
Mark Weintraub, MD's National Provider Identifier (NPI) is 1053342386, issued on 07/05/2006.
Does Mark Weintraub, MD prescribe more brand-name or generic drugs? ▼
Mark Weintraub, MD's prescribing is 12% brand-name and 88% generic drugs by claim count, with $1.6M in brand drug costs.
Does Mark Weintraub, MD prescribe opioids? ▼
Yes, Mark Weintraub, MD had 65 opioid claims in 2023 with an opioid prescribing rate of 2.6%.
How many Urology Physician providers are there in the US? ▼
There are 13,367 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,280 Medicare Part D claims per year.
What drugs does Mark Weintraub, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Weintraub, MD's most frequently prescribed drugs include Tamsulosin Hcl, Sulfamethoxazole-Trimethoprim, Alfuzosin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Weintraub, MD accept Medicare? ▼
Mark Weintraub, MD appears in CMS Medicare data with 2,453 Part D claims and 642 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Weintraub, MD's credentials? ▼
Mark Weintraub, MD's NPI is 1053342386 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.